Shizan Xu
- Molecular Biology
- Epidemiology top 10%
- Cancer Research top 5%
- Hepatology top 5%
- Pharmacology top 2%
- Topics
- Liver Disease Diagnosis and Treatment (8 papers)Liver physiology and pathology (5 papers)Cancer, Hypoxia, and Metabolism (4 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Shizan Xu
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 570
- Epidemiology 389
- Cancer Research 321
- Hepatology 275
- Pharmacology 194
Countries citing papers authored by Shizan Xu
This map shows the geographic impact of Shizan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shizan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shizan Xu more than expected).
Fields of papers citing papers by Shizan Xu
This network shows the impact of papers produced by Shizan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shizan Xu. The network helps show where Shizan Xu may publish in the future.
Co-authorship network of co-authors of Shizan Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Shizan Xu. A scholar is included among the top collaborators of Shizan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shizan Xu. Shizan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | 39 | |
| 3 | 42 | |
| 4 | 26 | |
| 5 | 30 | |
| 6 | 62 | |
| 7 | 38 | |
| 8 | 17 | |
| 9 | 36 | |
| 10 | 53 | |
| 11 | 214 | |
| 12 | 38 | |
| 13 | 35 | |
| 14 | 30 | |
| 15 | 12 | |
| 16 | 56 | |
| 17 | 62 | |
| 18 | 27 | |
| 19 | 81 | |
| 20 | 2 |
About Shizan Xu
Shizan Xu is a scholar working on Hepatology, Pharmacology and Geriatrics and Gerontology, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Liver physiology and pathology (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Hepatology (275 citations), Pharmacology (194 citations) and Cancer Research (321 citations). Shizan Xu has collaborated with scholars based in China and United States. Frequent co-authors include Jingjing Li, Jiao Feng, Chuanyong Guo, Sainan Li, Liwei Wu, Yujing Xia, Kan Chen, Yingqun Zhou, Xiaoming Fan and Jie Lu. Their work appears in journals such as Scientific Reports, British Journal of Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.